Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAC2 | P15153 | 1/20 | 0.33 |
| ▸ | RAC3 | P60763 | 1/20 | 0.33 |
| ▸ | CDC42 | P60953 | 1/20 | 0.33 |
| ▸ | RAC1 | P63000 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18868051 | 0.95 | L3MBTL1 (0.33) | L3MBTL1KDM4EATMALDH1A1HPGD | |
| SCHEMBL18561386 | 0.94 | L3MBTL1 (0.35) | RAC2RAC3CDC42RAC1L3MBTL1 | |
| SCHEMBL24217117 | 0.92 | KDM4E (0.31) | RAC2RAC3CDC42RAC1L3MBTL1 | |
| SCHEMBL22192377 | 0.92 | L3MBTL1 (0.38) | L3MBTL1KDM4EATMALDH1A1HPGD | |
| SCHEMBL26630475 | 0.92 | KDM4E (0.33) | RAC2RAC3CDC42RAC1L3MBTL1 | |
| SCHEMBL21965567 | 0.91 | PLA2G2A (0.33) | KDM4EALDH1A1HPGDTSHRMAPT | |
| SCHEMBL21965496 | 0.91 | PLA2G2A (0.33) | KDM4EALDH1A1HPGDTSHRMAPT | |
| SCHEMBL15625543 | 0.91 | MAPT (0.36) | L3MBTL1KDM4EATMALDH1A1HPGD | |
| SCHEMBL22192390 | 0.91 | KDM4E (0.38) | L3MBTL1KDM4EATMALDH1A1HPGD | |
| SCHEMBL21018296 | 0.91 | KDM4E (0.32) | RAC2RAC3CDC42RAC1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11569452-B2 | Organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-01-31 | — | — | US | disclosed |
| US-20200194681-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2020-06-18 | — | — | US | disclosed |
| US-10615348-B2 | Organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-04-07 | — | — | US | disclosed |
| US-20190393424-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-12-26 | — | — | US | disclosed |
| US-20190157603-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
| US-20170141323-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
| US-20170141323-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11569452-B2 | Organic light-emitting device | CRY1, TRPA1, CRY2 | RAC2 4601/4885RAC3 4630/4885CDC42 3203/4885 |
| US-20190393424-A1 | ORGANIC LIGHT-EMITTING DEVICE | OR10J3, LIN28A, OR51E2 | RAC2 3712/4885RAC3 3540/4885CDC42 1896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.